Stephen Breazeale1, Samantha Conley2, Sangchoon Jeon2, Susan G Dorsey3, Joan Kearney2, Brad Yoo4, Nancy S Redeker2. 1. Yale School of Nursing, 400 West Campus Drive, Orange, CT, 06477, USA; The University of Pittsburgh School of Nursing, 3500 Victoria Street, Victoria Building, Pittsburgh, PA, 15261, USA. Electronic address: stb134@pitt.edu. 2. Yale School of Nursing, 400 West Campus Drive, Orange, CT, 06477, USA. 3. University of Maryland School of Nursing, 655 W. Lombard Street, Baltimore, MD, 21201, USA. 4. Yale School of Medicine, 47 College Place, New Haven, CT, 06510, USA.
Abstract
BACKGROUND: Millions of Americans experience traumatic orthopaedic injuries (TOIs) annually. Post-injury symptoms of acute stress disorder (ASD), anxiety, depression, pain, and sleep disturbance are common. Symptoms often present in clusters. Symptom cluster profiles phenotypically characterize TOI survivors' experiences with clustered symptoms. Expression of brain-derived neurotrophic factor (BDNF) may contribute to the biological underpinnings of symptom cluster profile membership. METHODS: We recruited hospitalized TOI survivors within 72 hours of injury. We measured symptoms of ASD with the Acute Stress Disorder Scale and symptoms of anxiety, depression, pain, and sleep disturbance with Patient-Reported Outcomes Measurement Information System (PROMIS) short forms. We measured serum BDNF concentrations with enzyme-linked immunosorbent assay (ELISA) and identified rs6265 genotypes with TaqMan real-time PCR. We performed latent profile analysis to identify the symptom cluster profiles. We identified the variables associated with symptom cluster profile membership with unadjusted and adjusted multinomial logistic regression. RESULTS: We identified 4 symptom cluster profiles characterized by symptom severity that we labelled Physical Symptoms Only, and Mild, Moderate, and Severe Psychological Distress. Age, self-identified Black race, resilience, and serum BDNF concentrations were associated with lower odds, and female sex with higher odds, of being in the Psychological Distress clusters. Clinical characteristics and rs6265 genotypes were not associated with symptom cluster profile membership. CONCLUSION: TOI survivors experience distinct symptom cluster profiles. Sociodemographic characteristics and serum BDNF concentrations, not clinical characteristics, were associated with symptom cluster profile membership. These findings support comprehensive symptom screening and treatment for all TOI survivors and further evaluating BDNF as a biomarker of post-injury symptom burden.
BACKGROUND: Millions of Americans experience traumatic orthopaedic injuries (TOIs) annually. Post-injury symptoms of acute stress disorder (ASD), anxiety, depression, pain, and sleep disturbance are common. Symptoms often present in clusters. Symptom cluster profiles phenotypically characterize TOI survivors' experiences with clustered symptoms. Expression of brain-derived neurotrophic factor (BDNF) may contribute to the biological underpinnings of symptom cluster profile membership. METHODS: We recruited hospitalized TOI survivors within 72 hours of injury. We measured symptoms of ASD with the Acute Stress Disorder Scale and symptoms of anxiety, depression, pain, and sleep disturbance with Patient-Reported Outcomes Measurement Information System (PROMIS) short forms. We measured serum BDNF concentrations with enzyme-linked immunosorbent assay (ELISA) and identified rs6265 genotypes with TaqMan real-time PCR. We performed latent profile analysis to identify the symptom cluster profiles. We identified the variables associated with symptom cluster profile membership with unadjusted and adjusted multinomial logistic regression. RESULTS: We identified 4 symptom cluster profiles characterized by symptom severity that we labelled Physical Symptoms Only, and Mild, Moderate, and Severe Psychological Distress. Age, self-identified Black race, resilience, and serum BDNF concentrations were associated with lower odds, and female sex with higher odds, of being in the Psychological Distress clusters. Clinical characteristics and rs6265 genotypes were not associated with symptom cluster profile membership. CONCLUSION: TOI survivors experience distinct symptom cluster profiles. Sociodemographic characteristics and serum BDNF concentrations, not clinical characteristics, were associated with symptom cluster profile membership. These findings support comprehensive symptom screening and treatment for all TOI survivors and further evaluating BDNF as a biomarker of post-injury symptom burden.
Authors: Kristin R Archer; Sara E Heins; Christine M Abraham; William T Obremskey; Stephen T Wegener; Renan C Castillo Journal: Clin J Pain Date: 2016-03 Impact factor: 3.442
Authors: Nicholas J Drayer; Christopher S Wallace; Henry H Yu; Taylor D Mansfield; Danielle L Cummings; Debra K Hood; Edward D Arrington; Daniel G Kang Journal: Mil Med Date: 2020-02-12 Impact factor: 1.437
Authors: Casey M Beleckas; Melissa Wright; Heidi Prather; Aaron Chamberlain; Jason Guattery; Ryan P Calfee Journal: J Hand Surg Am Date: 2018-02-01 Impact factor: 2.230
Authors: Eva Visser; Brenda Leontine Den Oudsten; Taco Gosens; Paul Lodder; Jolanda De Vries Journal: Qual Life Res Date: 2021-01-14 Impact factor: 4.147